Pediatrix Medical Group, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $324.9m
$320.4m -1.40%
$268.6m -16.15%
($1.5b) -657.54%
($796.5m) +46.82%
$131.0m +116.44%
$66.3m -49.35%
($60.4m) -191.07%
($99.1m) -64.00%
$165.4m +266.94%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $324.6m $320.4m $268.6m ($1.5b) ($796.5m) $130.9m $66.3m ($60.4m) ($99.1m) $165.4m
Net Income (Loss) Attributable to Noncontrolling Interest ($318k) $27k ($4k) $0 $0
Depreciation, Depletion and Amortization $89.3m $102.9m $111.3m $78.9m $28.4m $32.1m $35.6m $36.2m $32.2m $21.8m $23.1m
Depreciation $29.0m $33.9m $38.5m $30.0m $19.3m $21.6m $26.7m $28.1m $22.7m $14.3m $23.1m
Amortization of Debt Issuance Costs and Discounts $4.8m $5.5m $4.6m $5.7m $7.2m $4.3m $1.8m $1.2m $954k $935k
Amortization of Intangible Assets $60.3m $68.9m $72.8m $48.9m $7.6m $8.0m $6.4m $5.6m $7.1m $5.7m
Depreciation Amortization Depletion $35.6m $36.2m $32.2m $21.8m $23.1m
Deferred Income Tax Expense (Benefit) $18.1m ($60.1m) ($24.1m) ($177.0m) $36.3m ($31.2m) ($22.8m) $3.2m ($2.1m) $52.2m $55.5m
Deferred Other Tax Expense (Benefit) $10.8m
Deferred Tax ($22.8m) $3.2m ($2.1m) $52.2m $55.5m
Share-based Payment Arrangement, Noncash Expense $34.0m $29.6m $38.7m $35.4m $39.0m $19.0m $16.1m $12.3m $11.9m $18.0m $20.2m
Share-based Payment Arrangement, Expense $34.0m $29.6m $38.7m $35.4m $21.1m $19.0m $14.4m $12.3m $9.9m $11.7m $20.2m
Goodwill and Intangible Asset Impairment $168.3m $178.4m $0
Goodwill, Impairment Loss $1.4b $148.3m $150.6m ($3.6m)
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $7.7m
Operating Lease, Impairment Loss $12.5m
Asset Impairment Charge $0 $168.3m $178.4m $0 ($3.6m)
Income (Loss) from Equity Method Investments $3.2m $952k $6.8m $7.8m $1.6m $1.9m $1.7m $2.1m $2.3m $3.6m
Nonoperating Income (Expense) ($57.9m) ($69.7m) ($77.0m) ($105.9m) ($91.0m) ($67.7m) ($91.3m) ($55.7m) ($32.6m) $7.6m
Changes in operating assets and liabilities:
Change In Working Capital $31.8m ($11.6m) $88.2m $41.8m $606k
Increase (Decrease) in Accounts Receivable $34.0m ($7.8m) $36.6m ($7.9m) ($37.9m) $72.7m $5.5m ($26.3m) ($10.3m) ($30.6m) $11.4m
Change In Receivables ($5.5m) $26.3m $10.3m $30.6m $11.4m
Changes In Account Receivables ($5.5m) $26.3m $10.3m $30.6m $11.4m
Change In Payables And Accrued Expense $420k ($11.9m) $51.1m $28.3m ($2.4m)
Change In Other Current Assets $17.2m $22.9m $33.7m $21.8m $19.4m
Change In Other Current Liabilities ($14.4m) ($27.7m) ($5.4m) ($34.7m) ($27.4m)
Net Cash Provided by (Used in) Operating Activities $443.8m
$511.4m +15.23%
$289.9m -43.31%
$346.6m +19.56%
$204.6m -40.97%
$76.7m -62.50%
$166.9m +117.55%
$137.3m -17.74%
$206.6m +50.43%
$271.1m +31.23%
$249.5m -7.95%
Cash flows from investing activities:
Capital Expenditure ($29.7m) ($33.3m) ($22.0m) ($18.5m) ($18.3m)
Gain (Loss) on Investments $20.9m
Gain (Loss) on Sale of Investments $20.9m
Payments to Acquire Investments $61.0m $27.7m $15.9m $35.1m $61.8m $15.1m $17.3m $31.9m $64.5m $29.9m ($18.4m)
Unrealized Gain (Loss) on Investments ($5.1m) $1.5m $1.1m $1.7m
Payments to Acquire Businesses, Net of Cash Acquired $762.3m $531.7m $114.5m $112.0m $2.2m ($29.9m) $28.2m $6.7m $8.2m $23.2m ($30.2m)
Payments for (Proceeds from) Other Investing Activities ($6.7m) $0 $3.5m
Net Other Investing Changes $1.4m $807k $6.8m ($3.5m) $697k
Net Cash Provided by (Used in) Investing Activities ($142.8m) $102.5m $815.5m ($53.1m) ($57.0m) ($48.2m) ($35.4m) ($18.3m) ($9.6m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($14.5m) ($57.0m) $0 $0
Issuance Of Debt $1.5b $470.0m $235.5m $0 $0
Long Term Debt Issuance $1.5b $470.0m $235.5m $0 $0
Long Term Debt Payments ($1.9b) ($489.1m) ($250.9m) ($20.8m) ($23.8m)
Net Issuance Payments Of Debt ($405.2m) ($19.1m) ($15.4m) ($20.8m) ($23.8m)
Net Long Term Debt Issuance ($405.2m) ($19.1m) ($15.4m) ($20.8m) ($23.8m)
Repayment Of Debt ($1.9b) ($489.1m) ($250.9m) ($20.8m) ($23.8m)
Payments for Repurchase of Common Stock $61.8m $70.2m $302.2m $145.3m $8.5m $4.7m $88.5m $919k $1.7m $86.7m
Proceeds from Issuance of Common Stock $22.0m $23.3m $16.3m $11.3m $7.0m $6.9m $5.4m $4.9m $3.6m $3.2m $3.0m
Common Stock Issuance $5.4m $4.9m $3.6m $3.2m $3.0m
Common Stock Payments ($88.5m) ($919k) ($1.7m) ($86.7m) ($149.1m)
Issuance Of Capital Stock $5.4m $4.9m $3.6m $3.2m $3.0m
Net Common Stock Issuance ($83.1m) $4.0m $1.9m ($83.5m) ($146.1m)
Repurchase Of Capital Stock ($88.5m) ($919k) ($1.7m) ($86.7m) ($149.1m)
Proceeds from (Payments for) Other Financing Activities $596k $9.4m ($8.8m) $135k ($63k)
Net Other Financing Charges $732k ($10.6m) ($1.0m) ($3.2m) ($1.2m)
Net Cash Provided by (Used in) Financing Activities ($170.6m)
($393.1m) -130.39%
($4.2m) +98.94%
($760.1m) -18180.81%
($487.6m) +35.86%
($25.7m) +94.73%
($14.5m) +43.67%
($107.5m) -642.11%
($173.1m) -61.01%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($23.5m) $56.0m $1.0b ($736.5m) ($377.6m) $63.4m $156.7m $145.3m $288.9m
Beginning Cash Position $387.4m $9.8m $73.3m $229.9m $224.7m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $80.2m $56.7m $112.8m $288.9m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $60.5m $73.8m $82.5m $95.4m $110.5m $86.5m $116.2m $42.3m $40.0m $34.4m
Income Taxes Paid, Net $176.0m $75.4m $185.4m $86.3m ($27.8m) $54.7m $26.9m $30.8m $4.7m $1.7m
Additional Financial Items
Gain (Loss) on Disposition of Business ($9.7m) $0
Gain (Loss) on Sale of Properties ($7.3m) $0 $0
General and Administrative Expense $372.6m $417.1m $432.4m $404.6m $248.9m $263.4m $231.4m $227.5m $238.4m $240.8m
Goodwill $3.8b $4.3b $4.4b $2.7b $1.5b $1.5b $1.5b $1.4b $1.2b $1.3b ($3.6m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($1.2b) ($9.6m) $108.0m $62.6m ($60.4m) ($99.1m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($347.6m) ($786.9m) $22.9m $3.8m $0 $0
Income Tax Expense (Benefit) $189.2m $90.0m $100.2m ($91.9m) $16.7m $27.2m $18.8m $12.0m ($2.3m) $51.0m
Interest Expense Nonoperating $40.7m $36.0m
Operating Expenses $2.6b $3.0b $3.2b $4.6b $1.6b $1.7b $1.8b $2.0b $2.1b $1.7b
Payments of Financing Costs $3.5m $7.1m $9.2m $510k $8.6m $0 $0
Proceeds from Noncontrolling Interests $894k $0 $245k $0
Revenue from Contract with Customer, Including Assessed Tax $3.6b $3.5b $1.7b $1.9b $2.0b $2.0b $2.0b $1.9b
Cash Flow From Continuing Financing Activities ($487.6m) ($25.7m) ($14.5m) ($107.5m) ($173.1m)
Cash Flow From Continuing Investing Activities ($57.0m) ($48.2m) ($35.4m) ($18.3m) ($9.6m)
Cash From Discontinued Financing Activities $0 $0 $0
Cash From Discontinued Investing Activities $2.4m $0 $0
Change In Cash Supplemental As Reported ($377.6m) $63.4m $156.7m $145.3m
Change In Other Working Capital $18.2m ($21.7m) ($5.0m) ($1.2m) ($1.2m)
Change In Prepaid Assets $15.9m $514k $3.5m ($2.9m) $836k
Changes In Cash ($377.6m) $63.4m $156.7m $145.3m $64.1m
End Cash Position $9.8m $73.3m $229.9m $375.2m $288.9m
Financing Cash Flow ($487.6m)
($25.7m) +94.73%
($14.5m) +43.67%
($107.5m) -642.11%
($173.1m) -61.01%
Free Cash Flow $137.2m $104.0m $184.6m $252.6m $228.6m
Gain Loss On Sale Of Business $0 $0 $9.7m ($20.9m) ($1.2m)
Gain Loss On Sale Of PPE ($7.3m) $0 $0
Investing Cash Flow ($57.0m) ($48.2m) ($35.4m) ($18.3m) ($9.6m)
Net Business Purchase And Sale ($28.2m) ($6.7m) ($8.2m) $6.8m ($196k)
Net Investment Purchase And Sale ($457k) ($9.0m) ($12.1m) ($3.2m) $8.1m
Net PPE Purchase And Sale ($29.7m) ($33.3m) ($22.0m) ($18.5m) ($18.3m)
Operating Gains Losses $7.3m $57.0m $9.7m ($20.9m) ($20.9m)
Other Non Cash Items $1.9m ($1.9m) ($2.0m) ($3.6m)
Purchase Of Business ($28.2m) ($6.7m) ($8.2m) ($23.2m) ($30.2m)
Purchase Of Investment ($17.3m) ($31.9m) ($64.5m) ($29.9m) ($18.4m)
Purchase Of PPE ($29.7m) ($33.3m) ($22.0m) ($18.5m) ($18.3m)
Sale Of Business $24.7m $0 $0 $30.0m $30.0m
Sale Of Investment $16.9m $22.9m $52.5m $26.7m $26.5m
Sale Of PPE $24.7m $0 $0
Stock Based Compensation $16.1m $12.3m $11.9m $18.0m $20.2m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.